Cargando…

Replication of a distinct psoriatic arthritis risk variant at the IL23R locus

Detalles Bibliográficos
Autores principales:	Budu-Aggrey, Ashley, Bowes, John, Loehr, Sabine, Uebe, Steffen, Zervou, Maria I, Helliwell, Philip, Ryan, Anthony W, Kane, David, Korendowych, Eleanor, Giardina, Emiliano, Packham, Jonathan, McManus, Ross, FitzGerald, Oliver, McHugh, Neil, Behrens, Frank, Burkhardt, Harald, Huffmeier, Ulrike, Ho, Pauline, Martin, Javier, Castañeda, Santos, Goulielmos, George, Reis, Andre, Barton, Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2016
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941176/ https://www.ncbi.nlm.nih.gov/pubmed/27016051 http://dx.doi.org/10.1136/annrheumdis-2016-209290

Ejemplares similares

PTPN22 is associated with susceptibility to psoriatic arthritis but not psoriasis: evidence for a further PsA-specific risk locus
por: Bowes, John, et al.
Publicado: (2015)

Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis
por: Bowes, John, et al.
Publicado: (2015)

Corrigendum: Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis
por: Bowes, John, et al.
Publicado: (2015)

Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis
por: Hüffmeier, Ulrike, et al.
Publicado: (2010)

Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis
por: Bowes, John, et al.
Publicado: (2011)

Variants in linkage disequilibrium with the late cornified envelope gene cluster deletion are associated with susceptibility to psoriatic arthritis
por: Bowes, John, et al.
Publicado: (2010)

Comprehensive assessment of rheumatoid arthritis susceptibility loci in a large psoriatic arthritis cohort
por: Bowes, John, et al.
Publicado: (2012)

Cross-phenotype association mapping of the MHC identifies genetic variants that differentiate psoriatic arthritis from psoriasis
por: Bowes, John, et al.
Publicado: (2017)

Evidence to support IL-13 as a risk locus for psoriatic arthritis but not psoriasis vulgaris
por: Bowes, John, et al.
Publicado: (2011)

A rare coding allele in IFIH1 is protective for psoriatic arthritis
por: Budu-Aggrey, Ashley, et al.
Publicado: (2017)

Identifying a novel locus for psoriatic arthritis
por: Budu-Aggrey, Ashley, et al.
Publicado: (2016)

Identification of low-frequency TRAF3IP2 coding variants in psoriatic arthritis patients and functional characterization
por: Böhm, Beate, et al.
Publicado: (2012)

Comparative Genetic Analysis of Psoriatic Arthritis and Psoriasis for the Discovery of Genetic Risk Factors and Risk Prediction Modeling
por: Soomro, Mehreen, et al.
Publicado: (2022)

KIF3A and IL-4 are disease-specific biomarkers for psoriatic arthritis susceptibility
por: Cascella, Raffaella, et al.
Publicado: (2017)

Genome-wide association and targeted analysis of copy number variants with psoriatic arthritis in German patients
por: Uebe, Steffen, et al.
Publicado: (2017)

Treatment recommendations for psoriatic arthritis
por: Ritchlin, C T, et al.
Publicado: (2009)

Axial Disease in Psoriatic Arthritis study: defining the clinical and radiographic phenotype of psoriatic spondyloarthritis
por: Jadon, Deepak R, et al.
Publicado: (2017)

Psoriatic arthritis: from pathogenesis to therapy
por: FitzGerald, Oliver, et al.
Publicado: (2009)

Cardiovascular Comorbidities in Psoriatic Disease
por: Szentpetery, Agnes, et al.
Publicado: (2019)

Early Origins of Psoriatic Arthritis: Clinical, Genetic and Molecular Biomarkers of Progression From Psoriasis to Psoriatic Arthritis
por: Pennington, Stephen R., et al.
Publicado: (2021)

Mannan-induced Nos2 in macrophages enhances IL-17–driven psoriatic arthritis by innate lymphocytes
por: Zhong, Jianghong, et al.
Publicado: (2018)

The many faces of psoriatic arthritis: their genetic determinism
por: Winchester, Robert, et al.
Publicado: (2020)

Early biomarkers of joint damage in rheumatoid and psoriatic arthritis
por: Mc Ardle, Angela, et al.
Publicado: (2015)

Psoriatic arthritis synovial histopathology: commentary on the article by Kruithof and colleagues
por: FitzGerald, Oliver
Publicado: (2005)

Application of information theoretic feature selection and machine learning methods for the development of genetic risk prediction models
por: Jalali-najafabadi, Farideh, et al.
Publicado: (2021)

Effect of tofacitinib on dactylitis and patient-reported outcomes in patients with active psoriatic arthritis: post-hoc analysis of phase III studies
por: Orbai, Ana-Maria, et al.
Publicado: (2022)

Ustekinumab in the Treatment of Psoriasis and Psoriatic Arthritis
por: Savage, Laura J., et al.
Publicado: (2015)

Efficacy of tofacitinib on enthesitis in patients with active psoriatic arthritis: analysis of pooled data from two phase 3 studies
por: Mease, Philip J., et al.
Publicado: (2023)

Relationships between psoriatic arthritis composite measures of disease activity with patient-reported outcomes in phase 3 studies of tofacitinib
por: Coates, Laura C., et al.
Publicado: (2021)

Deletion of LCE3C and LCE3B genes at PSORS4 does not contribute to susceptibility to psoriatic arthritis in German patients
por: Hüffmeier, Ulrike, et al.
Publicado: (2009)

Tumor necrosis factor polymorphisms in psoriatic arthritis: association with the promoter polymorphism TNF-857 independent of the PSORS1 risk allele
por: Reich, K, et al.
Publicado: (2007)

Serum bone-turnover biomarkers are associated with the occurrence of peripheral and axial arthritis in psoriatic disease: a prospective cross-sectional comparative study
por: Jadon, Deepak R., et al.
Publicado: (2017)

Concepts of pathogenesis in psoriatic arthritis: genotype determines clinical phenotype
por: FitzGerald, Oliver, et al.
Publicado: (2015)

The role of the multidisciplinary team in the management of psoriatic arthritis
por: Jadon, Deepak R., et al.
Publicado: (2022)

Qualifying Unmet Needs and Improving Standards of Care in Psoriatic Arthritis
por: Helliwell, Philip, et al.
Publicado: (2014)

Comment on: homozygous variant p. Arg90His in NCF1 is associated with early-onset interferonopathy: a case report
por: Goulielmos, George N., et al.
Publicado: (2021)

The top 10 research priorities in psoriatic arthritis: a James Lind Alliance Priority Setting Partnership
por: Hailey, Louise, et al.
Publicado: (2022)

A randomized placebo-controlled trial of methotrexate in psoriatic arthritis
por: Kingsley, Gabrielle H., et al.
Publicado: (2012)

Biomarkers predictive of treatment response in psoriasis and psoriatic arthritis: a systematic review
por: Magee, Conor, et al.
Publicado: (2021)

Disease-specific composite measures for psoriatic arthritis are highly responsive to a Janus kinase inhibitor treatment that targets multiple domains of disease
por: Helliwell, Philip, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jho3lmq04qcvi6ujj7gl5i5g14